Orchard Therapeutics’ Lenmeldy Approved In U.S. To Treat Rare Genetic DisorderUnderstanding The Enormously Expensive Drug Therapy Treatment, Costing $4.25 Million

With 7,000 known rare diseases existing across the globe, and approximately 95 percent of those having no treatment, according to the National Organization For Rare Disorders, its exciting to hear that the first therapy for the rare genetic disorder known as metachromatic leukodystrophy MLD has been approvedbut it comes with a whopping wholesale price of $4.25 million.